<DOC>
	<DOCNO>NCT00092469</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , immune response investigational vaccine evaluate reduce incidence diphtheria , pertussis , tetanus , hepatitis B , poliomyelitis , Haemophilus influenza type b .</brief_summary>
	<brief_title>Study Investigational Vaccine Healthy Infants Taiwan ( V441-001 ) ( COMPLETED )</brief_title>
	<detailed_description>The duration treatment 65 week .</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant receive Hepatitis B vaccine within 5 day birth whose mother negative Hepatitis B surface antigen Problems immune system Recent illness fever</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>8 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>